Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Revenue

Gan & Lee Pharmaceuticals. had revenue of 1.34B CNY in the quarter ending June 30, 2026, with 24.31% growth. This brings the company's revenue in the last twelve months to 4.21B, up 10.83% year-over-year. In the year 2025, Gan & Lee Pharmaceuticals. had annual revenue of 4.05B with 33.06% growth.

• Revenue (ttm): 4.21B
• Revenue Growth: +10.83%
• P/S Ratio: 9.79
• Revenue / Employee: 792.69K
• Employees: 5,309
• Market Cap: 41.19B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.05B	1.01B	33.06%
Dec 31, 2024	3.05B	437.31M	16.77%
Dec 31, 2023	2.61B	895.77M	52.31%
Dec 31, 2022	1.71B	-1.90B	-52.60%
Dec 31, 2021	3.61B	250.16M	7.44%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error